Novavax (NVAX) –
-
Form SC 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
-
Form SC 13D NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
-
Shah Capital nominates two directors to board of Novavax (NVAX)
-
Shah Capital nominates two highly qualified independent director candidates for Novavax
-
Novavax (NVAX) Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate
-
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
-
Form 4 NOVAVAX INC For: Mar 01 Filed by: O'Hara Elaine
-
Form 4 NOVAVAX INC For: Mar 01 Filed by: Trizzino John
-
Form 4 NOVAVAX INC For: Mar 01 Filed by: Kelly James Patrick
-
Form 4 NOVAVAX INC For: Mar 01 Filed by: Dubovsky Filip
-
Form 4 NOVAVAX INC For: Mar 01 Filed by: Casey Mark J
-
Form 4 NOVAVAX INC For: Mar 01 Filed by: Jacobs John C
-
Form 8-K NOVAVAX INC For: Mar 22
-
Form 4 NOVAVAX INC For: Mar 10 Filed by: Kelly James Patrick
-
Form 4 NOVAVAX INC For: Mar 10 Filed by: Dubovsky Filip
-
Form 4 NOVAVAX INC For: Mar 10 Filed by: Trizzino John
-
Form 4 NOVAVAX INC For: Mar 07 Filed by: Dubovsky Filip
-
Form 4 NOVAVAX INC For: Sep 12 Filed by: Kelly James Patrick
-
Form 4 NOVAVAX INC For: Mar 07 Filed by: Trizzino John
-
Form SC 13G/A NOVAVAX INC Filed by: MORGAN STANLEY
-
Form 4 NOVAVAX INC For: Mar 01 Filed by: O'Hara Elaine
-
Novavax to Participate in TD Cowen's 44th Annual Health Care Conference
-
Novavax (NVAX) crashes 20% on wider quarterly loss and soft guidance
-
Novavax says still faces strong headwinds, 2024 sales flat to lower
-
Form 8-K NOVAVAX INC For: Feb 28
-
Novavax (NVAX) Misses Q4 EPS by 99c ; Offers Guidance
-
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
-
Form 10-K NOVAVAX INC For: Dec 31
-
Novavax (NVAX) PT Lowered to $11 at B.Riley
-
Form 8-K NOVAVAX INC For: Feb 16
-
Novavax (NVAX) and Gavi Settle on 2021 COVID-19 Vaccine Advance Purchase Agreement
-
Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
-
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
-
Form SC 13G/A NOVAVAX INC Filed by: VANGUARD GROUP INC
-
Form SC 13G NOVAVAX INC Filed by: MORGAN STANLEY
-
Novavax (NVAX) approved an approximately 12% reduction of its global workforce
-
Form 8-K NOVAVAX INC For: Jan 30
-
Form SC 13G/A NOVAVAX INC Filed by: BlackRock Inc.
-
Form 4 NOVAVAX INC For: Jan 23 Filed by: Jacobs John C
-
Form SC 13G/A NOVAVAX INC Filed by: STATE STREET CORP
-
Form 8-K NOVAVAX INC For: Jan 08
-
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
-
Form 4 NOVAVAX INC For: Dec 14 Filed by: Trizzino John
-
Form 4 NOVAVAX INC For: Dec 14 Filed by: Herrmann John A III
-
Form 4 NOVAVAX INC For: Dec 14 Filed by: Dubovsky Filip
-
Novavax (NVAX) Announces Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan
-
Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan
-
Form 4 NOVAVAX INC For: Dec 11 Filed by: Casey Mark J
-
Form 3 NOVAVAX INC For: Dec 11 Filed by: Casey Mark J
-
Novavax's (NVAX) Updated COVID-19 Vaccine Now Authorized in Canada
Back to NVAX Stock Lookup